Related Experiment Videos
Prediction Models for Postoperative Delirium Among Cancer Patients: A Scoping Review
Chaoqun Ma1, Yao Wu1, Jiawen He1
1School of Nursing, Guangdong Pharmaceutical University, Guangzhou 510310, China.
Healthcare (Basel, Switzerland)
|July 28, 2026
Summary
Existing postoperative delirium (POD) prediction models for cancer patients show promise but need more external validation and transparency for clinical use. These tools are best for risk stratification, not definitive decision-making.
Area of Science:
- Oncology
- Geriatrics
- Anesthesiology
- Medical Informatics
Background:
- Postoperative delirium (POD) is a significant concern in cancer patients, impacting recovery and outcomes.
- Accurate prediction models are crucial for early intervention and improved patient management.
- Current models for POD prediction in cancer patients require systematic evaluation.
Purpose of the Study:
- To systematically map existing postoperative delirium (POD) prediction models in cancer patients.
- To analyze study design, modeling techniques, performance evaluation, and reporting standards of these models.
- To assess the readiness of current POD models for clinical implementation.
Main Methods:
- Systematic mapping following the Arksey and O'Malley framework and PRISMA-ScR guidelines.
- Searched nine databases from inception to April 2026.
- Narrative synthesis of 32 included studies on POD prediction models in cancer patients.
Main Results:
- Thirty-two studies were included, with most showing a high risk of bias.
- Logistic regression was common; key predictors included age, operation time, and nutritional/inflammatory indicators.
- Model performance showed promising discrimination (AUC 0.690–0.973), but external validation and clinical utility assessment were often insufficient.
Conclusions:
- Existing POD prediction models for cancer patients demonstrate good discrimination but are not yet ready for routine clinical use.
- Limitations include inadequate external validation, inconsistent clinical utility assessment, and lack of model transparency.
- Future research should focus on standardized reporting, multicenter validation, and decision-curve analysis for safe clinical translation.